Your browser is no longer supported. Please, upgrade your browser.
Globus Medical, Inc.
Index- P/E63.21 EPS (ttm)1.00 Insider Own0.70% Shs Outstand98.96M Perf Week-4.98%
Market Cap6.30B Forward P/E29.54 EPS next Y2.15 Insider Trans-28.94% Shs Float97.81M Perf Month-1.61%
Income102.30M PEG4.88 EPS next Q0.37 Inst Own68.00% Short Float1.43% Perf Quarter9.63%
Sales789.00M P/S7.99 EPS this Y-33.40% Inst Trans-1.30% Short Ratio2.62 Perf Half Y15.99%
Book/sh15.22 P/B4.17 EPS next Y16.31% ROA6.60% Target Price71.13 Perf Year24.12%
Cash/sh4.29 P/C14.77 EPS next 5Y12.94% ROE7.30% 52W Range33.41 - 68.24 Perf YTD-2.79%
Dividend- P/FCF46.66 EPS past 5Y-2.90% ROI5.80% 52W High-7.09% Beta0.98
Dividend %- Quick Ratio4.90 Sales past 5Y7.70% Gross Margin72.40% 52W Low89.76% ATR1.68
Employees2200 Current Ratio6.80 Sales Q/Q10.30% Oper. Margin14.10% RSI (14)45.45 Volatility2.66% 2.45%
OptionableYes Debt/Eq0.00 EPS Q/Q18.10% Profit Margin13.00% Rel Volume0.96 Prev Close63.63
ShortableYes LT Debt/Eq0.00 EarningsFeb 17 AMC Payout0.00% Avg Volume531.81K Price63.40
Recom2.20 SMA20-1.03% SMA50-1.64% SMA20014.25% Volume512,786 Change-0.36%
Feb-18-21Resumed Needham Buy $65 → $75
Dec-08-20Initiated Citigroup Buy $72
Oct-20-20Initiated Stifel Hold $56
Aug-06-20Upgrade Northland Capital Market Perform → Outperform $65
Aug-06-20Reiterated Needham Buy $60 → $65
Jul-21-20Initiated Northland Capital Market Perform $50
Jul-06-20Downgrade Piper Sandler Overweight → Neutral $60 → $50
May-08-20Reiterated Needham Buy $63 → $60
Mar-18-20Upgrade BTIG Research Neutral → Buy $46
Jan-08-20Initiated SunTrust Buy $67
Dec-12-19Upgrade Wells Fargo Market Perform → Outperform $63
Aug-02-19Reiterated Needham Buy $52 → $56
May-24-19Downgrade Wells Fargo Outperform → Market Perform $41
May-03-19Reiterated Needham Buy $57 → $52
Feb-28-19Upgrade UBS Neutral → Buy $55
Jan-02-19Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-02-18Reiterated Needham Buy $58 → $65
Jun-27-18Downgrade BofA/Merrill Neutral → Underperform
Jun-01-18Initiated Cantor Fitzgerald Overweight
May-03-18Reiterated Needham Buy $57 → $58
Feb-18-21 12:30AM  
Feb-17-21 04:47PM  
Feb-10-21 12:31PM  
Jan-29-21 01:37AM  
Jan-28-21 04:30PM  
Jan-19-21 10:30AM  
Dec-21-20 04:33PM  
Dec-18-20 08:57AM  
Dec-09-20 04:30PM  
Dec-08-20 09:36AM  
Dec-07-20 01:17PM  
Dec-01-20 09:58AM  
Nov-27-20 11:31AM  
Nov-12-20 04:30PM  
Oct-29-20 11:08AM  
Oct-28-20 06:15PM  
Oct-21-20 12:32PM  
Oct-20-20 09:56AM  
Oct-16-20 04:30PM  
Oct-07-20 11:20AM  
Oct-06-20 10:27AM  
Oct-05-20 04:30PM  
Sep-17-20 10:34AM  
Sep-14-20 11:35PM  
Sep-04-20 12:08PM  
Aug-20-20 10:46AM  
Aug-10-20 08:20AM  
Aug-05-20 06:35PM  
Aug-04-20 11:25AM  
Jul-29-20 12:33PM  
Jul-21-20 04:15PM  
Jun-23-20 07:40PM  
Jun-09-20 10:05AM  
May-27-20 08:09AM  
May-20-20 03:56PM  
May-09-20 09:34AM  
May-08-20 09:30PM  
May-07-20 08:50PM  
Apr-30-20 07:36AM  
Apr-16-20 04:30PM  
Apr-07-20 10:23AM  
Mar-26-20 09:37AM  
Mar-21-20 11:30AM  
Mar-18-20 03:28PM  
Mar-12-20 08:00AM  
Mar-11-20 05:40PM  
Mar-04-20 01:35AM  
Feb-21-20 08:34AM  
Feb-20-20 06:05PM  
Feb-13-20 12:31PM  
Feb-06-20 04:30PM  
Feb-04-20 04:30PM  
Jan-31-20 09:41AM  
Jan-28-20 06:13PM  
Jan-16-20 09:43AM  
Jan-09-20 10:19AM  
Jan-08-20 04:30PM  
Jan-02-20 09:43AM  
Dec-19-19 09:19AM  
Dec-16-19 11:26AM  
Dec-13-19 04:15PM  
Dec-10-19 07:36AM  
Dec-08-19 03:47PM  
Dec-06-19 11:31AM  
Dec-03-19 01:12PM  
Nov-13-19 01:25AM  
Nov-12-19 09:41AM  
Nov-11-19 01:12PM  
Nov-07-19 10:23AM  
Nov-06-19 06:25PM  
Oct-31-19 11:15AM  
Oct-30-19 10:34AM  
Oct-28-19 08:58AM  
Oct-24-19 10:55AM  
Oct-16-19 04:15PM  
Oct-02-19 09:09AM  
Sep-24-19 08:30AM  
Sep-19-19 04:15PM  
Sep-18-19 11:16AM  
Sep-13-19 07:48PM  
Sep-06-19 07:36AM  
Sep-05-19 09:40AM  
Aug-31-19 09:31AM  
Globus Medical, Inc., a medical device company, focuses on the development and commercialization of implants that heal patients with musculoskeletal disorders. Its spine product portfolio includes a range of implant and surgical approach options that can be used to treat degenerative, deformity, tumor, and trauma conditions affecting the spine from the occiput to the sacrum. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and regenerative biologic products, such as allografts and synthetic alternatives that are adjunctive treatments used in combination with stabilizing implant hardware. In addition, it provides motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous distraction devices, and interventional pain management solutions to treat vertebral compression fractures; imaging, navigation, and robotic assisted surgery technology solutions; and hip and knee joint solutions, as well as distributes human cell, tissue, and cellular and tissue based products. Further, the company offers expandable spacer products, which include RISE, RISE-L, CALIBER, CALIBER-L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, and XPand; CREO thoracolumbar stabilization platform that offers instruments and implants for treating pathologies; CREO MIS and CREO MCS, options designed for less invasive surgery and minimal muscle disruption; CREO Derotation and CREO Rod Link Reducer systems, which help to streamline various derotation maneuvers for deformity correction; CREO Addition that provides a range of connectors; and CREO Fenestrated, a cement augmented pedicle screw system for patients with advanced stage tumors and limited life expectancy, as well as QUARTEX, an occipito-cervico-thoracic stabilization system. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Huller KellySVP, GC, Corporate SecretaryDec 28Option Exercise11.282,00022,5602,000Dec 29 05:49 PM
Huller KellySVP, GC, Corporate SecretaryDec 28Sale66.152,000132,3000Dec 29 05:49 PM
Demski David MPresident, CEODec 17Option Exercise24.1015,864382,322164,719Dec 18 04:39 PM
Demski David MPresident, CEODec 17Sale64.20164,71910,574,9600Dec 18 04:39 PM
Demski David MPresident, CEODec 16Option Exercise27.9752,3561,464,516201,211Dec 18 04:39 PM
Demski David MPresident, CEODec 16Sale64.2052,3563,361,255148,855Dec 18 04:39 PM
Davidar David DDirectorNov 24Sale60.0010,000600,000205,967Nov 27 04:26 PM
Davidar David DDirectorNov 24Sale60.0032,0001,920,000634,775Nov 27 04:26 PM
TOBIN JAMES RDirectorSep 02Option Exercise26.275,600147,1125,600Sep 03 04:46 PM
TOBIN JAMES RDirectorSep 02Sale56.855,600318,3600Sep 03 04:46 PM
TOBIN JAMES RDirectorAug 25Option Exercise26.2717,400457,09817,400Aug 26 04:30 PM
TOBIN JAMES RDirectorAug 25Sale54.4017,400946,5600Aug 26 04:30 PM
Douglas Robert AndrewDirectorAug 24Buy53.8861533,1362,005Aug 25 04:36 PM
Huller KellySVP, GC, Corporate SecretaryAug 06Option Exercise11.2812,000135,36012,000Aug 10 04:30 PM
Demski David MPresident, CEOAug 06Option Exercise36.12330,00011,920,394330,000Aug 10 04:33 PM
Demski David MPresident, CEOAug 06Sale56.39330,00018,608,4420Aug 10 04:33 PM
Huller KellySVP, GC, Corporate SecretaryAug 06Sale55.8512,000670,1400Aug 10 04:30 PM
Douglas Robert AndrewDirectorJul 22Buy47.7569032,9481,390Jul 24 05:00 PM
Douglas Robert AndrewDirectorJun 22Buy48.2070033,740700Jun 24 04:20 PM
Huller KellySVP, GC, Corporate SecretaryJun 11Option Exercise11.289,076102,3779,076Jun 15 04:33 PM
Huller KellySVP, GC, Corporate SecretaryJun 11Sale51.009,076462,8760Jun 15 04:33 PM
Scavilla Daniel TEVP, Chief Commercial OfficerMay 21Option Exercise25.48100,0002,548,250100,000May 26 04:30 PM
Scavilla Daniel TEVP, Chief Commercial OfficerMay 21Sale55.09100,0005,509,0000May 26 04:30 PM